Evidence-based public policy making for medicines across countries: findings and implications for the future
Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
Switching among biosimilars: a review of clinical evidence
Biological medicines have improved patients' outcomes, but their high costs may limit
access. Biosimilars, alternatives that have demonstrated high similarity in terms of quality …
access. Biosimilars, alternatives that have demonstrated high similarity in terms of quality …
Activities in Namibia to limit the prevalence and mortality from COVID-19 including community pharmacy activities and the implications
Considerable differences exist in prevalence and mortality rates from COVID-19 across
countries due to the extent of prevention measures instigated and their timeliness. There has …
countries due to the extent of prevention measures instigated and their timeliness. There has …
The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries; findings and …
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of
associated complications has appreciably increased global expenditure in recent years. The …
associated complications has appreciably increased global expenditure in recent years. The …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
Introduction Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
Diabetes among adults in Bangladesh: changes in prevalence and risk factors between two cross-sectional surveys
Objective/research question To investigate the change in the prevalence and risk factors of
diabetes among adults in Bangladesh between 2011 and 2018. Design The study used two …
diabetes among adults in Bangladesh between 2011 and 2018. Design The study used two …
Impact of the COVID-19 pandemic on dental and medical education in Bangladesh: a pilot study and the implications
K Chowdhury, M Haque, AB Lutfor… - … Journal of Medical …, 2022 - strathprints.strath.ac.uk
Objective: Lockdown and other measures, including the closure of universities, introduced
by Governments across countries in response to the COVID-19 pandemic have appreciably …
by Governments across countries in response to the COVID-19 pandemic have appreciably …
Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: findings and implications
Background: Monoclonal antibodies (mAbs) represent the most numerous and significant
group of biotherapeutics. While mAbs have undoubtedly improved treatment for many …
group of biotherapeutics. While mAbs have undoubtedly improved treatment for many …
Availability and use of long-acting insulin analogues including their biosimilars across Africa; findings and implications
Background: Prevalence rates of diabetes mellitus are growing across Africa with an
appreciable number likely to be on insulin to manage their condition. This has significant …
appreciable number likely to be on insulin to manage their condition. This has significant …
Assessing utilisation and expenditure on long-acting insulin analogues in Kenya; findings and implications for the future
S Opanga, LW Njeri, D Kimonge… - Scholars Academic …, 2021 - pureportal.strath.ac.uk
Prevalence rates for patients with diabetes mellitus are rising across countries including sub-
Saharan African countries, which will continue. As a result, there are an increasing number …
Saharan African countries, which will continue. As a result, there are an increasing number …